Schinkel Afred | The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
スポンサーリンク
概要
- SCHINKEL Alfred H.の詳細を見る
- 同名の論文著者
- The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapyの論文著者
関連著者
-
Schellens J
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Beijnen J
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Beijnen Jos
Slotervaart Hospital Department Of Pharmacy And Pharmacology
-
Schellens J.
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
Schellens J.
Department Of Medical Oncology Antoni Van Leeuwenhoek Hospital/the Netherlands Cancer Institute
-
Schinkel Afred
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
Beijnen Jos
University Of Utrecht Department Of Pharmaceutical Analysis
-
Sparidans R
Utrecht University Faculty Of Science Department Of Pharmaceutical Sciences Section Of Biomedical An
-
BEIJNEN Jos
University of Utrecht, Department of Pharmaceutical Analysis
-
LAGAS Jurjen
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
Lagas Jurjen
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
SPARIDANS Rolf
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
SCHELLENS Jan
Universiteit Utrecht, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedic
-
IUSUF Dilek
The Netherlands Cancer Institute, Division of Molecular Biology
-
SCHINKEL Alfred
The Netherlands Cancer Institute, Division of Molecular Biology
-
Iusuf Dilek
The Netherlands Cancer Institute Division Of Molecular Biology
-
ROSING Hilde
Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
SPARIDANS Rolf
Utrecht University, Faculty of Pharmacy, Department of Pharmaceutical Analysis
-
BEIJNEN Jos
Utrecht University, Faculty of Pharmacy, Department of Pharmaceutical Analysis
-
Rosing Hilde
Department Of Pharmacy & Pharmacology The Netherlands Cancer Institute/slotervaart Hospital
-
Beijnen Jos
Department Of Clinical Chemistry The Netherlands Cancer Institute
-
Beijnen Jos
Utrecht University Faculty Of Pharmacy Department Of Biomedical Analysis Division Of Drug Toxicology
-
Sparidans Rolf
Utrecht University Faculty Of Pharmacy Department Of Biomedical Analysis Division Of Drug Toxicology
-
SCHELLENS Jan
Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Section of Biomedical
-
SCHINKEL Afred
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
Tibben Matthijs
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Damen Carola
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
VLAMING Maria
The Netherlands Cancer Institute, Departments of Medical Oncology and Experimental Therapy
-
VAN MAANEN
Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute
-
LAGAS Jurjen
Department of Experimental Therapy, The Netherlands Cancer Institute
-
SCHINKEL Alfred
Department of Experimental Therapy, The Netherlands Cancer Institute
-
SCHELLENS Jan
Beta Faculty, Department of Pharmaceutical Sciences, Division of Biomedical Analysis, Utrecht Univer
-
Vlaming Maria
The Netherlands Cancer Institute Departments Of Medical Oncology And Experimental Therapy
-
Van Maanen
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
著作論文
- Liquid chromatography-tandem mass spectrometric assays for salinomycin in mouse plasma, liver brain and small intestinal contents and in OptiMEM cell culture medium
- Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates
- Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma
- Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite
- Liquid chromatography-tandem mass spectrometric assay for diclofenac and three primary metabolites in mouse plasma
- A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry